Yuji Nishimoto Selected Research

COVID-19

3/2024	Prophylactic Anticoagulation and Thrombosis in Hospitalized Patients with Clinically Stable COVID-19 at Admission: From the Practice-Based Observational Study.
3/2023	Risk Factors and Impact on Outcomes of Thrombosis in Patients with COVID-19 in Japan: From the CLOT-COVID Study.
1/2023	Association Between the Development of Thrombosis and Worsening of Disease Severity in Patients With Moderate COVID-19 on Admission　- From the CLOT-COVID Study.
1/2023	Mortality-associated Risk Factors in Hospitalized COVID-19 Patients in Japan: Findings of the CLOT-COVID Study.
12/2022	Real-World Management of Pharmacological Thromboprophylactic Strategies for COVID-19 Patients in Japan: From the CLOT-COVID Study.
10/2022	The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study.
9/2022	Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study.
5/2022	D-Dimer Values and Venous Thromboembolism in Patients With COVID-19 in Japan　- From the CLOT-COVID Study.
1/2022	Therapeutic-Dose vs. Prophylactic-Dose Anticoagulation Therapy for Critically Ill Patients With COVID-19 in a Practice-Based Observational Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuji Nishimoto Research Topics

Disease

19	Neoplasms (Cancer) 05/2024 - 04/2019
17	Hemorrhage 05/2024 - 01/2020
17	Venous Thromboembolism 05/2024 - 01/2020
9	COVID-19 03/2024 - 01/2022
5	Thromboembolism 04/2024 - 01/2019
5	Thrombosis (Thrombus) 03/2023 - 01/2016
4	Pulmonary Embolism 03/2024 - 11/2019
3	Venous Thrombosis (Deep-Vein Thrombosis) 04/2024 - 11/2023
3	Heart Failure 04/2024 - 12/2020
3	Acute Coronary Syndrome 12/2023 - 05/2014
2	Cardiogenic Shock 12/2023 - 02/2023
2	Rupture 12/2023 - 08/2021
2	Infections 12/2023 - 10/2022
2	Heart Diseases (Heart Disease) 01/2023 - 11/2022
2	Thrombophilia 01/2022 - 04/2019
2	Critical Illness (Critically Ill) 01/2022 - 09/2020
2	Neointima 09/2017 - 05/2015
2	Hyperplasia 09/2017 - 01/2016
2	Death (Near-Death Experience) 01/2017 - 05/2015
2	Myocardial Infarction 01/2017 - 05/2015
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 04/2024
1	Abdominal Pain (Pain, Abdominal) 12/2023
1	Hypertension (High Blood Pressure) 09/2023
1	Atrial Fibrillation 06/2023
1	Obesity 01/2023
1	Out-of-Hospital Cardiac Arrest 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 11/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	May-Thurner Syndrome 10/2021
1	Ischemia 01/2021
1	Neoplasm Metastasis (Metastasis) 10/2019
1	Chronic Renal Insufficiency 04/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Unstable Angina 05/2015
1	Atherosclerosis 05/2015

Drug/Important Bio-Agent (IBA)

13	AnticoagulantsIBA 05/2024 - 09/2022
5	vinyltriethoxysilane (VTES)IBA 04/2024 - 01/2019
4	edoxabanIBA 04/2024 - 11/2023
4	fibrin fragment D (D-dimer)IBA 03/2023 - 05/2022
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2024 - 05/2015
2	RivaroxabanIBA 04/2024 - 03/2024
2	Warfarin (Coumadin)FDA LinkGeneric 01/2024 - 12/2022
1	apixabanIBA 04/2024
1	Oxygen (Dioxygen)IBA 03/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2023
1	Serum AlbuminIBA 09/2023
1	Dichlorodiphenyldichloroethane (DDD)IBA 06/2023
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2023
1	monteplaseIBA 02/2023
1	Vitamin K FDA Link 11/2022
1	Heparin (Liquaemin)FDA LinkGeneric 02/2022
1	C-Reactive ProteinIBA 12/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2019
1	BESIBA 09/2017
1	MetalsIBA 09/2017
1	omega-Chloroacetophenone (Mace)IBA 01/2017
1	LipidsIBA 05/2014

Therapy/Procedure

19	Therapeutics 05/2024 - 05/2015
4	Extracorporeal Membrane Oxygenation 02/2023 - 01/2022
3	Artificial Respiration (Mechanical Ventilation) 01/2023 - 01/2022
3	Drug-Eluting Stents 09/2017 - 05/2015
3	Stents 09/2017 - 05/2015
2	Secondary Prevention 05/2024 - 01/2020
2	Thrombectomy 10/2021 - 01/2021
1	Patient Readmission 04/2024
1	Percutaneous Coronary Intervention 12/2023
1	Length of Stay 02/2023
1	Blood Transfusion (Blood Transfusions) 02/2023
1	Cardiopulmonary Resuscitation (CPR) 01/2023
1	Radiotherapy 11/2022
1	Chemoradiotherapy 11/2022
1	Conservative Treatment 08/2021
1	Vena Cava Filters (Inferior Vena Cava Filter) 12/2020
1	Enteral Nutrition (Feeding, Tube) 09/2020
1	Drug Therapy (Chemotherapy) 10/2019
1	Central Venous Catheters 05/2019